US › Healthcare

Eagle Pharmaceuticals Inc (EGRX)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.370.00%

Last close · 2026-08-04

Latest quarter · ended 2023-06-30

Revenue

$64.6M

Revenue YoY

-12.8%

Net profit

$5.2M

Profit YoY

+154.6%

EPS

$0.00

EPS estimate

$0.00

Net margin

8.0%

Key statistics

Market cap

$3.3M

P/E

2.5

Forward P/E

11.3

P/B

0.16

Book value

$19.25

EPS (TTM)

$0.10

52-week high

$3.73

52-week low

$0.00

50-day MA

$0.57

200-day MA

$0.51

Beta

0.63

Analyst view

Analysts rate Eagle Pharmaceuticals Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $17.00.

Shareholding

Institutions

54.77%

Largest institutional holders

Fund	Stake
Stanley-Laman Group Ltd	0.09%
Archer Investment Corporation	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Eagle Pharmaceuticals Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.